Zai Lab Ltd

ZLABHONG KONG EXCHANGES AND CLEARING LTD

Health CareBiotechnology

$17.69

-0.790000 (-4.27%)

As of 05/29/26 EDT · USD

Compare

52-Week Low: $15.96Current: $17.6952-Week High: $44.34

Key Statistics

Open

$18.05

Day High

$18.05

Day Low

$17.60

Prev. Close

$18.48

Volume

852.64K

Avg. Volume

—

Market Cap

$2.01B

P/E (TTM)

-10.95

Forward P/E

—

P/B Ratio

—

52W High

$44.34

52W Low

$15.96

50D MA

$20.32

200D MA

$23.00

Dividend Yield

—

Beta

—

Performance

-7.4%

-14.7%

-11.1%

YTD

+2.1%

-41.3%

About

Richard B. Gaynor is an American physician specializing in hematology-oncology, educator, drug developer, and business executive. He served as an associate professor of medicine at UCLA School of Medicine for nearly a decade, and subsequently as an endowed Professor of Medicine and Microbiology at the University of Texas Southwestern Medical School prior to joining the pharmaceutical industry in 2002. His research on NF-κB, IκB kinase, and other mechanisms regulating viral and cellular gene expression has been covered in leading subject reviews. He has been a top executive at several pharmaceutical companies, with respect to the development and clinical testing of novel anticancer drugs and cell therapies. For over a decade and a half, he worked at Eli Lilly and Company, where he became the Senior Vice President of Oncology Clinical Development and Medical Affairs in 2013. Gaynor was President of R&D at Neon Therapeutics from 2016 to 2020, when he became the President of BioNTech US, both pharmaceutical companies headquartered in Cambridge, MA. His honors include being elected a member of the American Society for Clinical Investigation, and the Association of American Physicians.

www.zailaboratory.com/